MIST PPF Study now enrolling

Learn More

Phase 1b ATLAS Study

A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis

Read Our Publication

Phase 2b MIST Study

A Phase 2b Study Evaluating the Safety and Efficacy of AP01 (inhaled pirfenidone) in Participants With Progressive Pulmonary Fibrosis (PPF)

Learn more about MIST PPF Study

visit clinical trials.GOV >